Ambu A/S (AMBBY)
USD 14.18
(0.0%)
USD 14.18
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.85 Billion DKK | -4.93% |
| 2022 | 7.21 Billion DKK | 25.7% |
| 2021 | 5.74 Billion DKK | 16.52% |
| 2020 | 4.92 Billion DKK | 8.07% |
| 2019 | 4.55 Billion DKK | 7.65% |
| 2018 | 4.23 Billion DKK | 69.36% |
| 2017 | 2.5 Billion DKK | 5.66% |
| 2016 | 2.36 Billion DKK | 4.97% |
| 2015 | 2.25 Billion DKK | 10.11% |
| 2014 | 2.04 Billion DKK | 8.25% |
| 2013 | 1.89 Billion DKK | 95.86% |
| 2012 | 965.5 Million DKK | 8.59% |
| 2011 | 889.15 Million DKK | 1.52% |
| 2010 | 875.87 Million DKK | 12.05% |
| 2009 | 781.66 Million DKK | 6.75% |
| 2008 | 732.22 Million DKK | 7.56% |
| 2007 | 680.77 Million DKK | 0.45% |
| 2006 | 677.73 Million DKK | 3.0% |
| 2005 | 658 Million DKK | 11.32% |
| 2004 | 591.1 Million DKK | 6.31% |
| 2003 | 556.03 Million DKK | -1.27% |
| 2002 | 563.19 Million DKK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 7.28 Billion DKK | 3.21% |
| 2024 Q2 | 7.06 Billion DKK | 3.26% |
| 2024 Q1 | 6.83 Billion DKK | -0.31% |
| 2023 Q3 | 6.82 Billion DKK | -1.63% |
| 2023 Q1 | 7 Billion DKK | -2.9% |
| 2023 FY | 6.85 Billion DKK | -4.93% |
| 2023 Q4 | 6.85 Billion DKK | 0.51% |
| 2023 Q2 | 6.93 Billion DKK | -0.98% |
| 2022 Q1 | 6.32 Billion DKK | 10.23% |
| 2022 Q3 | 6.92 Billion DKK | 5.55% |
| 2022 Q4 | 7.21 Billion DKK | 4.25% |
| 2022 FY | 7.21 Billion DKK | 25.7% |
| 2022 Q2 | 6.55 Billion DKK | 3.64% |
| 2021 Q1 | 5.04 Billion DKK | 2.38% |
| 2021 Q3 | 5.56 Billion DKK | 4.68% |
| 2021 FY | 5.74 Billion DKK | 16.52% |
| 2021 Q2 | 5.31 Billion DKK | 5.45% |
| 2021 Q4 | 5.74 Billion DKK | 3.11% |
| 2020 Q1 | 4.68 Billion DKK | 2.68% |
| 2020 FY | 4.92 Billion DKK | 8.07% |
| 2020 Q2 | 4.78 Billion DKK | 2.31% |
| 2020 Q4 | 4.92 Billion DKK | 1.03% |
| 2020 Q3 | 4.87 Billion DKK | 1.84% |
| 2019 Q4 | 4.55 Billion DKK | 4.61% |
| 2019 Q1 | 4.26 Billion DKK | 0.66% |
| 2019 Q2 | 4.41 Billion DKK | 3.66% |
| 2019 FY | 4.55 Billion DKK | 7.65% |
| 2019 Q3 | 4.35 Billion DKK | -1.38% |
| 2018 FY | 4.23 Billion DKK | 69.36% |
| 2018 Q1 | 4.12 Billion DKK | 64.88% |
| 2018 Q3 | 4.22 Billion DKK | 2.95% |
| 2018 Q4 | 4.23 Billion DKK | 0.31% |
| 2018 Q2 | 4.1 Billion DKK | -0.53% |
| 2017 Q3 | 2.5 Billion DKK | -0.24% |
| 2017 FY | 2.5 Billion DKK | 5.66% |
| 2017 Q1 | 2.53 Billion DKK | 6.97% |
| 2017 Q2 | 2.5 Billion DKK | -0.95% |
| 2017 Q4 | 2.5 Billion DKK | -0.04% |
| 2016 Q1 | 2.27 Billion DKK | 0.75% |
| 2016 Q2 | 2.3 Billion DKK | 1.32% |
| 2016 Q3 | 2.25 Billion DKK | -2.22% |
| 2016 Q4 | 2.36 Billion DKK | 5.16% |
| 2016 FY | 2.36 Billion DKK | 4.97% |
| 2015 Q4 | 2.25 Billion DKK | -1.49% |
| 2015 FY | 2.25 Billion DKK | 10.11% |
| 2015 Q3 | 2.28 Billion DKK | -3.5% |
| 2015 Q2 | 2.37 Billion DKK | 12.53% |
| 2015 Q1 | 2.1 Billion DKK | 2.93% |
| 2014 Q1 | 1.9 Billion DKK | 0.58% |
| 2014 Q2 | 1.92 Billion DKK | 1.21% |
| 2014 Q4 | 2.04 Billion DKK | 3.7% |
| 2014 Q3 | 1.97 Billion DKK | 2.55% |
| 2014 FY | 2.04 Billion DKK | 8.25% |
| 2013 Q3 | 1.94 Billion DKK | -2.66% |
| 2013 FY | 1.89 Billion DKK | 95.86% |
| 2013 Q4 | 1.89 Billion DKK | -2.96% |
| 2013 Q2 | 2 Billion DKK | 104.41% |
| 2013 Q1 | 979.3 Million DKK | 1.43% |
| 2012 Q4 | 965.5 Million DKK | -4.29% |
| 2012 Q1 | 941.9 Million DKK | 5.93% |
| 2012 Q2 | 948.2 Million DKK | 0.67% |
| 2012 Q3 | 1 Billion DKK | 6.39% |
| 2012 FY | 965.5 Million DKK | 8.59% |
| 2011 FY | 889.15 Million DKK | 1.52% |
| 2011 Q3 | 866.6 Million DKK | -1.28% |
| 2011 Q2 | 877.8 Million DKK | -2.64% |
| 2011 Q1 | 901.6 Million DKK | 2.94% |
| 2011 Q4 | 889.15 Million DKK | 2.6% |
| 2010 Q3 | 902.6 Million DKK | 5.21% |
| 2010 FY | 875.87 Million DKK | 12.05% |
| 2010 Q2 | 857.9 Million DKK | 5.84% |
| 2010 Q1 | 810.6 Million DKK | 3.7% |
| 2010 Q4 | 875.87 Million DKK | -2.96% |
| 2009 Q4 | 781.66 Million DKK | 0.0% |
| 2009 FY | 781.66 Million DKK | 6.75% |
| 2008 FY | 732.22 Million DKK | 7.56% |
| 2007 FY | 680.77 Million DKK | 0.45% |
| 2006 FY | 677.73 Million DKK | 3.0% |
| 2005 FY | 658 Million DKK | 11.32% |
| 2004 FY | 591.1 Million DKK | 6.31% |
| 2003 FY | 556.03 Million DKK | -1.27% |
| 2002 FY | 563.19 Million DKK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AVITA Medical, Inc. | 144.33 Million USD | -4651.975% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -2170469.62% |
| Össur hf. | 1.39 Billion USD | -392.104% |
| QHSLab, Inc. | 1.68 Million USD | -407826.101% |
| Wellstar International, Inc. | 957.89 Thousand USD | -715951.496% |
| Össur hf. | 1.39 Billion USD | -392.104% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 4.75 Million USD | -144059.481% |
| Aurora Spine Corporation | 11.92 Million USD | -57423.821% |
| BrainsWay Ltd. | 62.97 Million USD | -10792.143% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 144.38 Thousand USD | -4750294.77% |
| Hamilton Thorne Ltd. | 110.16 Million USD | -6126.204% |
| Vivos Inc. | 1.61 Million USD | -425892.035% |
| Kelyniam Global, Inc. | 1.63 Million USD | -420003.216% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -568491.594% |
| Zecotek Photonics Inc. | 2.57 Million USD | -266487.068% |
| Avitar, Inc. | 1.74 Million USD | -392330.592% |
| Nanomix Corporation | 982.05 Thousand USD | -698333.387% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | -6564.349% |
| Theraclion SA | 18.66 Million EUR | -36650.74% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.76 Million USD | -387929.304% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -916409.327% |
| Lombard Medical, Inc. | 67.76 Million USD | -10021.446% |
| ALR Technologies Inc. | 193.21 Thousand USD | -3549794.678% |
| Stratec SE | 529.71 Million USD | -1194.85% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -691123.806% |
| Heart Tronics, Inc. | 4.04 Million USD | -169302.529% |
| MicroPort Scientific Corporation | 3.93 Billion USD | -74.47% |
| VMS Rehab Systems, Inc. | 4.45 USD | -154134831360.674% |
| NewCardio, Inc. | 2.85 Million USD | -240309.049% |
| Guided Therapeutics, Inc. | 1.66 Million USD | -410864.649% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -929633.862% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -1504749.789% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -12528211.536% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -3764857.734% |
| SANUWAVE Health, Inc. | 22.41 Million USD | -30498.68% |
| IR-Med Inc. | 999 Thousand USD | -686486.587% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | -33291.15% |
| Polarean Imaging plc | 10.86 Million USD | -63016.157% |
| United American Healthcare Corporation | 10.37 Million USD | -65985.365% |
| ECGI Holdings, Inc. | 5.2 Million USD | -131768.14% |
| Nu-Med Plus, Inc. | 2.21 Million USD | -309976.468% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -20296402.338% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | -320604.643% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -787592.746% |
| Urologix, Inc. | 5.66 Million USD | -120934.057% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | -304125.177% |
| Nexeon MedSystems Inc. | 20.35 Million USD | -33602.768% |
| SS Innovations International, Inc. | 25.47 Million USD | -26820.118% |
| Qualis Innovations, Inc. | 2431.00 USD | -282147164.5% |
| Smith & Nephew plc | 9.97 Billion USD | 31.224% |
| NIOX Group Plc | 116.47 Million USD | -5788.59% |
| Fuse Medical, Inc. | 16.25 Million USD | -42085.415% |
| Broncus Holding Corporation | 195.75 Million USD | -3403.926% |
| Brain Scientific Inc. | 11.74 Million USD | -58306.157% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -653339.728% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -23869745.137% |